More Manzo Pharmaceuticals, Inc. news
Manzo Pharmaceuticals, Inc.OTC: MNZO

Shareholder Meeting

Feb 24, 2022 · Issued by Manzo Pharmaceuticals, Inc.

On 6ix: 6ix.com/news/shareholder-meeting

The original release is unavailable here.

Manzo Pharmaceuticals, Inc. on 6ix

Earlier from Manzo Pharmaceuticals

  • Virtual Special MeetingFeb 22, 2022
  • SEC Suspension of TradingMar 9, 2018
  • New Manzo Pharmaceuticals, Inc. WebsiteOct 31, 2016
  • Manzo Pharmaceuticals, Inc announced today that the company's President, Kenneth Manzo, has received a verbal Wells Notice from the US Securities and Exchange Commission.Jul 29, 2016
  • Manzo Pharmaceuticals solidifies deal with USA based manufacturers to begin producing the company's lactose intolerance probiotic, Lacto-FreedomMar 24, 2016
All Manzo Pharmaceuticals news releases↗

Follow Manzo Pharmaceuticals into a list and get an email when it puts out news.

Follow Manzo Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer